News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
V. Lokesh Battula: Our findings on resistance to Fluorothymidine 3 inhibitors in Acute Myeloid Leukemia are now published in the Leukemia Journal
Photo from V. Lokesh Battula/LinkedIn
Dec 1, 2023, 19:13

V. Lokesh Battula: Our findings on resistance to Fluorothymidine 3 inhibitors in Acute Myeloid Leukemia are now published in the Leukemia Journal

V. Lokesh Battula, Associate Professor at MD Anderson Cancer Center, shared on LinkedIn:

“Happy to report that our findings on resistance to FLT3 inhibitors in AML are now published in the Leukemia Journal. In this report, we have reported ACVR1 as a novel resistance factor for FLT3 inhibitors in AML and introduced a novel FLT3-ACVR1 dual inhibitor (TP-0184) as a single agent to target both FLT3 and its resistance factor in AML!”

V. Lokesh Battula: Our findings on resistance to Fluorothymidine 3 inhibitors in Acute Myeloid Leukemia are now published in the Leukemia Journal V. Lokesh Battula: Our findings on resistance to Fluorothymidine 3 inhibitors in Acute Myeloid Leukemia are now published in the Leukemia Journal

Read the article here.
Source: V. Lokesh Battula/LinkedIn

AML cancer FLT3 inhibitors Leukemia Journal OncoDaily Oncology publication V. Lokesh Battula
Special Coverage
Science
Dec 22, 2024, 10:15
Dégi László Csaba: Thrilled to announce the new Lancet Oncology Policy Review analyzing NCCPs worldwide
Science
Dec 22, 2024, 10:13
Denis Horgan: Delayed Access to Personalized Medicine in the EU - What’s the Cost to Patients?
Blog
Dec 22, 2024, 10:12
Emad Shash: Honor to be among the newly elected council of the Egyptian Cancer Society
Science
Dec 22, 2024, 10:03
María Natalia Gandur Quiroga: Checkpoint inhibitors and Fc functions - key findings in oncology immunotherapy
Science
Dec 22, 2024, 10:00
Francesco Maura: CD38 loss as mechanisms of resistance to anti-CD38 MoAb in myeloma
Science
Dec 22, 2024, 09:59
CDK4/6 inhibitors: mechanisms of resistance and where to find them - Lorenzo Gerratana
Blog
Dec 22, 2024, 09:53
India's Oncology Testing Market Projected to Grow at 2% CAGR Through 2033: GlobalData
Dialogues
Dec 22, 2024, 09:40
Botensilimab: A Novel Anti-CTLA- 4 Therapy Effectively Treats Refractory Colorectal Cancers
Dialogues
Dec 22, 2024, 09:04
Carlos Rodriguez-Galindo: The Man Who Will Cure the World
Science
Dec 22, 2024, 08:16
Essential Requirements for Quality Cancer Care: Ovarian - European Cancer Organisation
Science
Dec 22, 2024, 08:13
Liang Cheng: Advancements in biomarkers and molecular diagnostics in HR+ Breast Cancer
Science
Dec 22, 2024, 07:59
Ilana Schlam: The BRIDGES study is out